JET FUEL provides fractional leadership, mentorship, and operational support to scale venture-backed startups.

ImageAiD develops an AI-powered Doppler platform to detect peripheral artery disease before symptoms appear.

Moonrise Medical automates vascular diagnostics for peripheral artery disease and diabetic foot wounds using AI-powered ultrasound.

Jetstream Venture Fund offers early-stage investment opportunities previously limited to elite networks.

Hill Research automates clinical trial data processing to generate FDA-required statistical packages.

Rejuvenate Bio researches treatments targeting the biological processes underlying chronic disease progression.

Jetstream invested in Rejuvenation Technologies, which develops mRNA therapies to extend telomeres and restore cellular regeneration.

Jetstream Venture Fund invested in Carbogenesis, which converts natural gas and CO₂ into high-value industrial chemicals.

Xcellerant Ventures manages the Jetstream fund, offering venture capital expertise to investors.

Jetstream Venture Fund offers venture capital opportunities with a $5,000 minimum investment.

Rejuvenate Bio, a San Diego-based gene therapy company, begins treating dogs with therapies targeting chronic, age-related diseases. The company develops innovative treatments for degenerative conditions. Jetstream Venture Fund, managed by Doug Sylvester, recently invested in Rejuvenate Bio, citing its potential as a standout venture this year.

Oct 2026Jetstream Venture FundNews article

Jetstream invests in Rejuvenation Technologies, a company focused on developing mRNA-based therapies. These therapies aim to extend telomeres and promote cellular regeneration, addressing aging at a biological level.

Sep 2026Jetstream Venture FundNews article

Xcellerant Ventures highlights Carbogenesis as a potential disruptor in clean technology by addressing fundamental challenges in the sector. The firm argues that transformative technologies succeed not just by solving problems, but by making previously impractical solutions feasible and economically viable. Carbogenesis is positioned as a company that could redefine industry standards through its innovative approach.

Aug 2026Jetstream Venture FundNews article

Hill Research applies artificial intelligence to streamline clinical development, addressing inefficiencies in bringing new therapies to patients. The company targets the complex, labor-intensive process of clinical trials, where precision and regulatory compliance are critical. By leveraging AI, Hill Research aims to accelerate the translation of scientific breakthroughs into approved treatments.

Jul 2026Jetstream Venture FundNews article